Cargando…
More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science ;, The Lancet Pub. Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132782/ https://www.ncbi.nlm.nih.gov/pubmed/37119830 http://dx.doi.org/10.1016/S1473-3099(23)00274-8 |
| _version_ | 1785031461275959296 |
|---|---|
| author | Monach, Paul A Branch-Elliman, Westyn |
| author_facet | Monach, Paul A Branch-Elliman, Westyn |
| author_sort | Monach, Paul A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10132782 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Science ;, The Lancet Pub. Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101327822023-04-27 More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants Monach, Paul A Branch-Elliman, Westyn Lancet Infect Dis Correspondence Elsevier Science ;, The Lancet Pub. Group 2023-06 2023-04-26 /pmc/articles/PMC10132782/ /pubmed/37119830 http://dx.doi.org/10.1016/S1473-3099(23)00274-8 Text en Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Monach, Paul A Branch-Elliman, Westyn More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title | More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title_full | More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title_fullStr | More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title_full_unstemmed | More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title_short | More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants |
| title_sort | more data needed on efficacy and safety of monovalent vaccines against sars-cov-2 omicron variants |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132782/ https://www.ncbi.nlm.nih.gov/pubmed/37119830 http://dx.doi.org/10.1016/S1473-3099(23)00274-8 |
| work_keys_str_mv | AT monachpaula moredataneededonefficacyandsafetyofmonovalentvaccinesagainstsarscov2omicronvariants AT branchellimanwestyn moredataneededonefficacyandsafetyofmonovalentvaccinesagainstsarscov2omicronvariants |